Odanacatib (MK0822)

odanacatib · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Odanacatib (MK0822), covering 2015-08-19 to 2015-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002) [Phase 1]